These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18408659)
1. In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation. Venesio T; Chiorino G; Balsamo A; Zaccagna A; Petti C; Scatolini M; Pisacane A; Sarotto I; Picciotto F; Risio M Mod Pathol; 2008 Jun; 21(6):716-26. PubMed ID: 18408659 [TBL] [Abstract][Full Text] [Related]
2. BRAF and NRAS mutations in melanoma and melanocytic nevi. Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322 [TBL] [Abstract][Full Text] [Related]
3. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. Uribe P; Andrade L; Gonzalez S J Invest Dermatol; 2006 Jan; 126(1):161-6. PubMed ID: 16417232 [TBL] [Abstract][Full Text] [Related]
4. Activation of the mitogen-activated protein kinase pathway in malignant melanoma can occur independently of the BRAF T1799A mutation. Yazdi AS; Ghoreschi K; Sander CA; Röcken M Eur J Dermatol; 2010; 20(5):575-9. PubMed ID: 20605766 [TBL] [Abstract][Full Text] [Related]
5. Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population. Wu D; Wang M; Wang X; Yin N; Song T; Li H; Yu J; Wang DM; Zhao Z Am J Dermatopathol; 2011 Jun; 33(4):341-4. PubMed ID: 21430505 [TBL] [Abstract][Full Text] [Related]
6. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Uribe P; Wistuba II; González S Am J Dermatopathol; 2003 Oct; 25(5):365-70. PubMed ID: 14501284 [TBL] [Abstract][Full Text] [Related]
7. Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals. Gao HW; Tsai WC; Perng CL; Wang WM; Chiang CP Eur J Dermatol; 2018 Aug; 28(4):509-518. PubMed ID: 30325319 [TBL] [Abstract][Full Text] [Related]
8. BRAF somatic mutations in malignant melanoma and melanocytic naevi. Thomas NE Melanoma Res; 2006 Apr; 16(2):97-103. PubMed ID: 16567964 [TBL] [Abstract][Full Text] [Related]
9. BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products. Hay R; MacRae E; Barber D; Khalil M; Demetrick DJ Arch Pathol Lab Med; 2007 Sep; 131(9):1361-7. PubMed ID: 17824790 [TBL] [Abstract][Full Text] [Related]
10. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. Yeh I; von Deimling A; Bastian BC J Natl Cancer Inst; 2013 Jun; 105(12):917-9. PubMed ID: 23690527 [TBL] [Abstract][Full Text] [Related]
11. NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi. Tschandl P; Berghoff AS; Preusser M; Burgstaller-Muehlbacher S; Pehamberger H; Okamoto I; Kittler H PLoS One; 2013; 8(7):e69639. PubMed ID: 23861977 [TBL] [Abstract][Full Text] [Related]
12. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features. Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212 [TBL] [Abstract][Full Text] [Related]
13. Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. Houben R; Vetter-Kauczok CS; Ortmann S; Rapp UR; Broecker EB; Becker JC J Invest Dermatol; 2008 Aug; 128(8):2003-12. PubMed ID: 18323787 [TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma. Takata M; Murata H; Saida T Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535 [TBL] [Abstract][Full Text] [Related]
15. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure. Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629 [TBL] [Abstract][Full Text] [Related]
16. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Wu J; Rosenbaum E; Begum S; Westra WH Am J Dermatopathol; 2007 Dec; 29(6):534-7. PubMed ID: 18032947 [TBL] [Abstract][Full Text] [Related]
17. BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients. Oyama S; Funasaka Y; Watanabe A; Takizawa T; Kawana S; Saeki H J Dermatol; 2015 May; 42(5):477-84. PubMed ID: 25766129 [TBL] [Abstract][Full Text] [Related]
18. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi. Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123 [TBL] [Abstract][Full Text] [Related]
19. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715 [TBL] [Abstract][Full Text] [Related]
20. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Viros A; Sanchez-Laorden B; Pedersen M; Furney SJ; Rae J; Hogan K; Ejiama S; Girotti MR; Cook M; Dhomen N; Marais R Nature; 2014 Jul; 511(7510):478-482. PubMed ID: 24919155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]